Literature DB >> 11351311

Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.

C Dong1, K Hemminki.   

Abstract

To assess the role of family history in the development of multiple primary cancer, the Swedish Family-Cancer Database was used to analyze second primary cancer in patients born in 1935 to 1996 with an initial primary cancer of the colon, breast and skin (melanoma) by familial cancer in first-degree relatives. Standardized incidence ratios (SIRs) were calculated from site-, sex- and age-specific rates for all persons (offspring) born in 1935 to 1996. Familial risk (SIR) was calculated for the first and second primary cancers in offspring. A Poisson regression analysis was also performed to assess the risk factors for occurrence of second primary cancer. The familial proportion of multiple primary cancers was 29.0% (9/31) for colon, 16.3% (122/747) for female breast and 14.5% (17/117) for melanoma. Compared with all offspring, patients with family history were at a much higher and significantly increased risk for subsequent primary cancer at colon (SIR = 59.1), skin (SIR = 48.2) and female breast (SIR = 7.9). The corresponding SIRs in patients without family history were 13.8, 10.5 and 5.2 at the three sites. The ratios for incidence of second primary to first primary were highest when diagnosis age was less than 40 years. A Poisson regression analysis showed that family history was one of the major risk factors for occurrence of multiple primary cancers at colon, breast and skin. The high risk of second cancer, even in the absence of family history, would be consistent with a polygenic model of carcinogenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11351311     DOI: 10.1002/ijc.1261

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.

Authors:  Won-Suk Lee; Jung Nam Lee; Sangtae Choi; Min Jung; Jeong-Heum Baek; Woon Kee Lee
Journal:  Langenbecks Arch Surg       Date:  2009-09-09       Impact factor: 3.445

2.  Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.

Authors:  H R Yun; L J Yi; Y K Cho; J H Park; Y B Cho; S H Yun; H C Kim; H K Chun; W Y Lee
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

3.  Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study.

Authors:  Denise Daley; Susan Lewis; Petra Platzer; Melissa MacMillen; Joseph Willis; Robert C Elston; Sanford D Markowitz; Georgia L Wiesner
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

4.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.

Authors:  C Dong; K Hemminki
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

5.  Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.

Authors:  Mala Pande; Aron Joon; Abenaa M Brewster; Wei V Chen; John L Hopper; Cathy Eng; Sanjay Shete; Graham Casey; Fredrick Schumacher; Yi Lin; Tabitha A Harrison; Emily White; Habibul Ahsan; Irene L Andrulis; Alice S Whittemore; Esther M John; Aung Ko Win; Enes Makalic; Daniel F Schmidt; Miroslaw K Kapuscinski; Heather M Ochs-Balcom; Steven Gallinger; Mark A Jenkins; Polly A Newcomb; Noralane M Lindor; Ulrike Peters; Christopher I Amos; Patrick M Lynch
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.